Lee Hyung Young, Jung Ki Tae
Department of Anesthesiology and Pain Medicine, Chosun University Hospital, School of Medicine, Chosun University, Gwangju, Korea.
Anesth Pain Med (Seoul). 2020 Jul 31;15(3):259-268. doi: 10.17085/apm.19099.
Sugammadex, a modified γ-cyclodextrin, is one of the drugs focused on in the anesthetic field because it provides rapid and complete reversal from neuromuscular blockade (NMB) by encapsulating rocuronium. Its introduction has revolutionized anesthesia practice because it is a safe, predictable, and reliable neuromuscular antagonist. Hence, its use has increased worldwide. Further, it has been in the spotlight for recovering from deep NMB in laparoscopic surgery and improving the surgical condition. Recently, studies have been conducted on the postoperative outcome after deep NMB and use of sugammadex in various clinical conditions. However, with increase in sugammadex use, reports regarding its complications are increasing. Appropriate dosing of sugammadex with quantitative neuromuscular monitoring is emphasized because under-dosing or over-dosing of sugammadex might be associated with unexperienced complications. Sugammadex is now leaping into an ideal reversal agent, changing the anesthesia practice.
舒更葡糖钠是一种改性γ-环糊精,是麻醉领域关注的药物之一,因为它通过包裹罗库溴铵可使神经肌肉阻滞(NMB)迅速且完全逆转。它的出现彻底改变了麻醉实践,因为它是一种安全、可预测且可靠的神经肌肉拮抗剂。因此,其在全球范围内的使用有所增加。此外,它在腹腔镜手术中从深度NMB恢复以及改善手术条件方面备受关注。最近,针对深度NMB后及在各种临床情况下使用舒更葡糖钠的术后结局开展了研究。然而,随着舒更葡糖钠使用的增加,关于其并发症的报告也在增多。强调使用定量神经肌肉监测来合理确定舒更葡糖钠的剂量,因为舒更葡糖钠剂量不足或过量可能会导致意想不到的并发症。舒更葡糖钠正跃身为一种理想的逆转剂,改变着麻醉实践。